Eli Lilly shares positive analysis from phase 3 trial for lebrikizumab for atopic dermatitis
May 3, 2023Research and Development Dermatology, Eli Lilly, Jenny Murase, atopic dermatitis, dermatology, lebrikizumab
Eli Lilly has announced new secondary analysis from its phase 3 clinical development programme for patients with atopic dermatitis (AD) …
FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children
April 28, 2023Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine
Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
Boehringer Ingelheim invests €350m in Europe’s largest biotech development centre
April 28, 2023Manufacturing and Production
Boehringer Ingelheim (BI) have announced that it will invest €350m in a state-of-the-art Biologicals Development Centre (BDC) in Germany. It …
Daewoong Pharmaceutical and Vitalli Bio enter Global License Agreement for autoimmune disease candidate
April 28, 2023Research and Development
South Korean Daewoong Pharmaceutical and US biotechnology company Vitalli Bio – a portfolio company of Aditum Bio – have announced …
Eli Lilly’s tirzepatide achieves 15.7% weight loss in adult patients
April 28, 2023Research and Development
Eli Lilly has announced that tirzepatide (10mg and 15mg) achieved significant and superior weight loss compared to a placebo over …
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
April 27, 2023Research and Development Avacta
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
April 27, 2023Business Services CHMP, Cosentyx, Dermatology, Novartis
Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …
GSK’s RSV vaccine candidate gains positive EMA CHMP opinion
April 27, 2023Medical Communications
GSK has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has shared a …
FDA approves first orally-administered faecal microbiota product for preventing serious gut infection
April 27, 2023Medical Communications
The US Food and Drug Administration (FDA) has announced that it has approved the first orally-ingested faecal microbiota product for …
National Institutes of Health awards grant for gammaCore clinical trial for patients with opioid use disorders
April 27, 2023Research and Development
Bioelectronic medicine and wellness company electroCore have announced that the National Institute on Drug Abuse (NIDA) part of the National …
NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund
April 27, 2023Medical Communications
The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to …
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
April 26, 2023Business Services
Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …
Epsilogen announces significant expansion of management team with three new senior hires
April 26, 2023Business Services
London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …
Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes
April 26, 2023Business Services
Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …
FDA shares safety warning on amniotic fluid eyedrops
April 26, 2023Medical Communications
The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being …
FDA grants accelerated approval for QALSODY (tofersen) as ALS treatment
April 26, 2023Medical Communications
Biogen has announced that the US Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100mg/15ml injection for the treatment …
UCB and Huma Therapeutics collaborate on digital health solution to improve rare disease management
April 26, 2023Medical Communications
Digital health company Huma Therapeutics and biopharmaceutical company UCB are partnering to offer a digital technology solution to aid patients …
Abbott announces two FDA clearances for life support system
April 26, 2023Medical Communications
US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …
MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
April 25, 2023Business Services
London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
Latest content
FibroFind appoints Lee Borthwick as CEO
